Abstract
The case of a 38-year-old woman with Addison’s disease, diabetes and recurrent severe hypoglycaemia is described. After some initial diagnostic uncertainty, it was confirmed that she had autoimmune diabetes. She subsequently developed recurrent episodes of severe hypoglycaemia with few or no warning symptoms. The options for managing this scenario are discussed, including increased blood glucose monitoring, carbohydrate counting, education on insulin adjustment, insulin pump therapy and islet cell transplants.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gangji AS, Cukierman T, Gerstein HC, Goldsmith CH, Clase CM. A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other insulin secretagogues and with insulin. Diabetes Care. 2007;30:389–94.
Marbury T, Huang W, Strange P, Lebovitz H. Repaglinide versus glyburide: a one-year comparison trial. Diabetes Res Clin Pract. 1999;43(3):155–66.
Ristic S, Collober-Maugeais C, Cressier F, Tang P, Pecher E, Ristic S, Collober-Maugeais C, Cressier F, et al. Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results. Diabetes Obes Metab. 2007;9(4):506–11.
Ristic S, Collober-Maugeais C, Pecher E, Cressier F. Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone. Diabet Med. 2006;23(7):757–62.
Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab. 2008;4:200–13.
Zammitt NN, Warren RE, Deary IJ, Frier BM. Delayed recovery of cognitive function following hypoglycemia in adults with type 1 diabetes. Effect of impaired awareness of hypoglycemia. Diabetes. 2008;57:732–6.
Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17:697–703.
Clarke WL, Cox DJ, Gonder-Frederick L, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18:517–22.
Geddes J, Wright RJ, Zammitt NN, Deary IJ, Frier BM. Evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes. Diabetes Care. 2007;30(7):1868–70.
Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med. 1991;8:217–22.
Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med. 2008;25:501–4.
Mühlhauser I, Heinemann L, Fritsche E, von Lennep K, Berger M. Hypoglycemic symptoms and frequency of severe hypoglycemia in patients treated with human and animal insulin preparations. Diabetes Care. 1991;14:745–9.
Orchard TJ, Maser RE, Becker DJ, Dorman JS, Drash AL. Human insulin use and hypoglycaemia: insights from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabet Med. 1991;8:469–74.
National Institute for Health and Clinical Excellence. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. NICE technology appraisal guidance 151; 2008. Ref Type: Online Source, London.
National Institute for Health and Clinical Excellence. Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus. Interventional procedure guidance 257; 2008. Ref Type: Online Source, London.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Zammitt, N.N., Frier, B.M. (2015). Hypoglycaemia Case Study. In: Ajjan, R., Orme, S. (eds) Endocrinology and Diabetes. Springer, London. https://doi.org/10.1007/978-1-4471-2789-5_17
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2789-5_17
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2788-8
Online ISBN: 978-1-4471-2789-5
eBook Packages: MedicineMedicine (R0)